Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Significant Enlargement of Exploration Program September 15, 2025 Completion of Non-Renounceable Pro-Rata Entitlement Offer September 15, 2025 Prismo Metals Identifies Porphyry Style Mineralization at Silver King September 15, 2025